Prophylactic Retinal Radiotherapy for Familial Retinoblastoma
Author Information
Author(s): P.N. Plowman, J.E. Kingston, J.L. Hungerford
Primary Institution: St. Bartholomew's Hospital, London
Hypothesis
Can prophylactic retinal radiotherapy reduce the risk of developing new retinoblastomas in high-risk infants?
Conclusion
Prophylactic retinal radiotherapy can significantly reduce the risk of new tumours in high-risk infants with retinoblastoma.
Supporting Evidence
- 14% of infants treated with external beam radiotherapy developed new tumours.
- 86% of control eyes developed retinoblastomas.
- 18% of patients required salvage therapy after treatment.
Takeaway
This study shows that giving special radiation treatment to babies at high risk of eye cancer can help prevent new cancers from developing.
Methodology
The study involved 33 infants with hereditary retinoblastoma who received whole eye or retinal radiotherapy and were followed for at least one year.
Potential Biases
Potential bias in patient selection and treatment outcomes due to the retrospective nature of the study.
Limitations
The study may underestimate the incidence risk of new tumours due to the small sample size and the nature of the cohort.
Participant Demographics
Infants with hereditary retinoblastoma, all with one affected parent.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website